Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | OAT | P04181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218786 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL14439278 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL799755 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL29550605 | 0.83 | GABRR1 (0.42) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL20363529 | 0.82 | GABRR1 (0.33) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL416062 | 0.82 | GABRR1 (0.33) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL17453292 | 0.79 | GABRR1 (0.32) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL419019 | 0.70 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL12929618 | 0.70 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL19215291 | 0.68 | NOS3 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020196424-A1 | WATER-SOLUBLE ADDITIVE COMPOSITION | 住友ベークライト株式会社 | 2020-10-01 | — | — | WO | disclosed |
| WO-2020040017-A1 | MEDICINAL PRODUCT, ANTICANCER AGENT, MEDICINAL INTERMEDIATE PRODUCT, AND METHOD FOR PRODUCING CYCLIC CARBOXYLIC ACID COMPOUND OR DERIVATIVE THEREOF | 住友ベークライト株式会社 | 2020-02-27 | — | — | WO | disclosed |